1. Home
  2. BON vs EDSA Comparison

BON vs EDSA Comparison

Compare BON & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bon Natural Life Limited

BON

Bon Natural Life Limited

N/A

Current Price

$1.70

Market Cap

14.6M

Sector

Health Care

ML Signal

N/A

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

HOLD

Current Price

$1.51

Market Cap

12.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BON
EDSA
Founded
2006
2015
Country
China
Canada
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6M
12.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BON
EDSA
Price
$1.70
$1.51
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
41.0K
49.7K
Earning Date
01-28-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.46
N/A
Revenue
$21,610,848.00
N/A
Revenue This Year
$223.38
N/A
Revenue Next Year
$18.82
N/A
P/E Ratio
$0.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$1.28
52 Week High
$73.75
$4.49

Technical Indicators

Market Signals
Indicator
BON
EDSA
Relative Strength Index (RSI) 48.59 47.63
Support Level $1.45 $1.43
Resistance Level $1.72 $1.55
Average True Range (ATR) 0.11 0.10
MACD 0.01 0.02
Stochastic Oscillator 68.56 79.41

Price Performance

Historical Comparison
BON
EDSA

About BON Bon Natural Life Limited

Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: